首页> 外文期刊>Cell cycle >Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging.
【24h】

Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging.

机译:细胞周期命运监测通过实时FUCCI成像证实了在药物治疗的异质群体中的个体化学敏感性和化学抗性癌细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

Essentially every population of cancer cells within a tumor is heterogeneous, especially with regard to chemosensitivity and resistance. In the present study, we utilized the fluorescence ubiquitination-based cell cycle indicator (FUCCI) imaging system to investigate the correlation between cell-cycle behavior and apoptosis after treatment of cancer cells with chemotherapeutic drugs. HeLa cells expressing FUCCI were treated with doxorubicin (DOX) (5 μM) or cisplatinum (CDDP) (5 μM) for 3 h. Cell-cycle progression and apoptosis were monitored by time-lapse FUCCI imaging for 72 h. Time-lapse FUCCI imaging demonstrated that both DOX and CDDP could induce cell cycle arrest in S/G2/M in almost all the cells, but a subpopulation of the cells could escape the block and undergo mitosis. The subpopulation which went through mitosis subsequently underwent apoptosis, while the cells arrested in S/G2/M survived. The present results demonstrate that chemoresistant cells can be readily identified in a heterogeneous population of cancer cells by S/G2/M arrest, which can serve in future studies as a visible target for novel agents that kill cell-cycle-arrested cells.
机译:基本上,肿瘤内的每个癌细胞群都是异质的,特别是在化学敏感性和耐药性方面。在本研究中,我们利用基于荧光泛素化的细胞周期指示剂(FUCCI)成像系统来研究化疗药物治疗癌细胞后细胞周期行为与细胞凋亡之间的相关性。将表达FUCCI的HeLa细胞用阿霉素(DOX)(5μM)或顺铂(CDDP)(5μM)处理3 h​​。通过延时FUCCI成像监测细胞周期进程和凋亡72小时。延时FUCCI成像表明DOX和CDDP均可诱导几乎所有细胞的S / G2 / M细胞周期停滞,但亚细胞群可逃脱该阻滞并发生有丝分裂。经历有丝分裂的亚群随后经历了凋亡,而滞留在S / G2 / M中的细胞得以存活。目前的结果表明,通过S / G2 / M阻滞可以在异质性癌细胞群中轻易鉴定出化学抗性细胞,这可以在未来的研究中用作杀死细胞周期被阻滞的细胞的新型药物的可见靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号